Sakai, Japan

Masayasu Tanaka

This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayasu Tanaka. Retrieved from https://idiyas.com/inventor/masayasu-tanaka-nqamdg94

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masayasu Tanaka: Innovator in Medicinal Chemistry

Introduction

Masayasu Tanaka is a notable inventor based in Sakai, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patent work. His expertise and dedication have positioned him as a valuable asset in the pharmaceutical industry.

Latest Patents

Tanaka holds a patent for a compound titled “[5-Chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinylamino]acetamide derivatives, process for producing the same, medicinal compositions containing the same and intermediate of these compounds.” This patent reflects his commitment to advancing medicinal chemistry and developing new therapeutic options.

Career Highlights

He is currently employed at Dainippon Pharmaceutical Company, Limited, where he continues to engage in groundbreaking research and development. His work has contributed to the advancement of pharmaceutical sciences and has the potential to impact patient care positively.

Collaborations

Tanaka has collaborated with esteemed colleagues, including Mari Itoh and Teruya Murata. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Masayasu Tanaka's contributions to medicinal chemistry through his patent work and collaborations highlight his role as an influential inventor in the pharmaceutical industry. His ongoing efforts continue to pave the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…